SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AI enthusiasm and AMDs powerful rally to new highs are driving attention, with traders citing demand for AI accelerators and CPUs as agentic AI workloads expand; some also speculate about a potential China chip deal, but that remains unconfirmed. Bulls celebrate momentum and a squeeze on short sellers, while skeptics warn that elevated valuation, dilution concerns, and rising bond yields leave the stock vulnerable to a pullback.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas Muse AI agent and its expansion into wearables, shopping and booking integrations, and new hardware are fueling a sharp rally. Bulls see potential for broader AI adoption and monetization, while skeptics question Muses usefulness and business prospects and warn that the stocks rapid climb may be overextended.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields climb to multi-decade highs amid sticky inflation concerns, hawkish Fed signals, and worries about government borrowing and bond demand. Many traders see further downside while yields keep rising, though others are buying the weakness and expect a rebound if economic conditions cool or geopolitical tensions ease.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys quarterly earnings beat and higher full-year outlook, led by record QNX growth and major automotive design wins, are driving attention; traders also highlight a reported Uber QNX selection and potential growth in robotics and autonomous vehicles. The reaction is split: many see stronger long-term prospects, while others question the muted, volatile share-price response and point to softer near-term guidance and Secure Communications concerns.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins pullback and choppy trading are driving attention to MSTR, which traders widely view as an amplified play on BTC; discussion is split between dip-buyers expecting a rebound and bears warning of further downside, with short squeezes and options volatility also recurring themes.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Pharvaris positive Phase 3 results for its oral HAE-prevention drug have raised concerns that it could compete with BioCrysts Orladeyo and add execution risk to the navenibart opportunity. Traders are divided over the threat, noting that competition is still some time away and BioCryst has an established product and commercial infrastructure.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais multiyear cloud-infrastructure agreement with Anthropic is driving attention, with traders viewing it as validation of the companys AI-computing opportunity. The bullish reaction is tempered by concerns that the buildout will require heavy capital spending and that Anthropics stock warrants could dilute shareholders.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels rally is being linked to expectations that Metas Muse and agentic-AI workloads will boost CPU demand, alongside broader semiconductor momentum. Bulls are celebrating the breakout, while skeptics warn the run may be overextended; talk of an imminent partnership or foundry announcement remains speculative.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

ARK Invests tokenization of its ARK Venture Fund through Securitize is driving attention, reinforcing the companys role in blockchain-based securities infrastructure. Traders are largely celebrating the sharp rally and broader tokenization opportunity, while some warn the move looks parabolic and are taking profits.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is being tied to the Phase 3 melanoma cancer-vaccine trial with Merck meeting its primary endpoints, reinforced by CEO Stphane Bancels comments on the companys broader mRNA platform and oncology pipeline. Bulls point to the potential beyond COVID vaccines and anticipate fuller trial data at ESMO, while skeptics question the treatments efficacy, commercial prospects, and the stocks valuation; short-squeeze chatter is also prominent.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Feed

News

Sentiment

Fundamentals

Info

FANH.DL1224 News